HIGHResearchTier 1

Fanconi anemia: matrix remodeling and oral carcinogenesis

SourceJournal of Dental Research (JDR)Tier 1Peer-Reviewed Research

By T.A. Silva, N.C.M. Santana, J.A.A. de Arruda, P.A. Rocha, S. Macari, V.Z. Drumond, W.C.S. Silva, L.M. Malard, J.M. Amenábar, C.C. Torres-Pereira, S. Del Marro, A. Pascual, A. Page, R. Errazquin, C. Lorz, R. Garcia-Escudero, F.C. Ferré, N. Dupré, A. Berdal, B.P.J. Fournier

Originally at journals.sagepub.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Oral surgeons, periodontists, and oral medicine specialists who treat Fanconi anemia patients face an elevated lifetime risk of oral squamous cell carcinoma; this study maps stromal matrix changes that may drive malignant transformation in this population.

Key points

  • Fanconi anemia raises the lifetime incidence of oral potentially malignant disorders and oral squamous cell carcinoma.
  • Researchers mapped extracellular matrix remodeling in FA-related oral lesions to clarify stromal drivers of carcinogenesis.
  • The study focused on the stromal alterations that remain poorly defined in FA patients who develop oral lesions.

Who should care

SpecialistAcademia

Read the original on Journal of Dental Research (JDR)

Full reporting and any paywall content live on journals.sagepub.com. We summarize and score; we do not republish.

Open original

Related